Elite Medical Competitors and Similar CompaniesClear all

Elite Medical's competitors and similar companies include Zhejiang Gongdong Medical Technology, Penumbra, Southern Prosthetic Supplies and Richard Wolf.

	Elite Medical Elite Medical is a medical and surgical equipment supplier.	Zhejiang Gongdong Medical Technology Zhejiang Gongdong Medical Technology is a manufacturer and supplier of medical devices and supplies.	Penumbra Penumbra is a healthcare company that designs, develops, and manufactures medical devices.	Southern Prosthetic Supplies Southern Prosthetic Supplies (SPS) is a company that distributes orthotic and prosthetic products.	Richard Wolf Richard Wolf is a supplier of products and solutions for endoscopy and extracorporeal shock wave treatment.
Founding Date	Founding Date 1986	Founding Date 1985	Founding Date 2004	Founding Date 1951	Founding Date 1906
Type	Type Private	Type Public	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare medical devices	Tags Healthcare medical devices	Tags Healthcare medical devices	Tags Retail distribution medical devices	Tags Healthcare medical devices
Locations	Locations Bulimba, AU HQ	Locations Taizhou, CN HQ Riverside, US	Locations Alameda, US HQ Darlinghurst, AU São Paulo, BR Berlin, DE Berlin, DE Rivoli, IT Alameda, US see more	Locations Alpharetta, US HQ Fresno, US	Locations Knittlingen, DE HQ Wien, AT Gent, BE Sao Paulo, BR Beijing, CN Shanghai, CN Reims, FR see more
Employees	Employees 1583% increase	Employees 1,693	Employees 4,2008% increase	Employees 1981% increase	Employees 1,800
Valuation ($)	Valuation ($) N/A	Valuation ($) 685 m	Valuation ($) 8.1 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥1.1b (FY, 2024)	Revenue (est.) $1.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €249.9m (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods ¥749.5m (FY, 2024)	Cost of goods $461.2m (FY, 2025)	Cost of goods N/A	Cost of goods €70.1m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit ¥352.8m (FY, 2024)	Gross profit $942.4m (FY, 2025)	Gross profit N/A	Gross profit €179.7m (FY, 2021)
Net income	Net income N/A	Net income ¥171.5m (FY, 2024)	Net income $177.7m (FY, 2025)	Net income N/A	Net income €4.1m (FY, 2021)